Often presents as a syndrome of exudative pharyngitis, fever, and bright-red exanthem (rash on skin). 10- to 14-day course of oral antibiotics indicated, generally rapid clinical improvement. Be sure to warn parents of the desquamation that occurs 1 to 2 weeks after the rash resolves and the dramatic peeling that may occur on the hands and feet. 12.1. Scarlatina. 12.2. Scarlatina. Minor criteria: To make the diagnosis of ARF, a patient needs 2 major criteria or 1 major plus 2 minor criteria. Treat the underlying streptococcal infection to reduce nonsuppurative complications; risk of rheumatic fever recurrence is greatest during the first 3 to 5 years; prophylaxis is recommended indefinitely in patients with established heart disease or if frequently exposed to streptococci. Just as it is important to emphasize the importance of immunizations to avoid the potentially serious complications of vaccine preventable diseases, it is important to encourage evaluation of children with sore throat with or without fever to exclude streptococcal pharyngitis. When symptoms of strep pharyngitis occur, it is important to confirm the diagnosis and treat early to nonsuppurative complications. Frequent prodrome of nonspecific upper respiratory symptoms, irritability, and occasionally low grade fever; high fever may indicate serious infection; 1- to 10-day incubation period.
CHAPTER
12
BACTERIAL RASHES
Scarlet Fever
Synonym
Scarlatina.
Inheritance
n/a
Prenatal Diagnosis
n/a
Incidence
Actual numbers of cases are not tracked but ~10% of patients who contract pharyngitis because of group A beta-hemolytic streptococcus (GABHS) will develop SF.
Age at Presentation
M = F; no racial predilection; typically seen in ages 4 to 15 years and most commonly in children of 4 to 8 years of age; rare under 1 to 3 years of age owing to protective maternal anti-exotoxin antibodies; by 10 years of age, ~80% of children have developed lifelong protective antibodies to causative streptococcal pyrogenic exotoxins; recurrences are rare due to cross reactivity of antibodies to exotoxins.
Pathogenesis
Associated with streptococcal pharyngitis though can rarely occur due to infection at other sites; cutaneous reaction to erythrogenic toxins A, B, and C produced by streptococci but most commonly group C.
Key Features
Differential Diagnosis
Some toxin producing staphylococci may produce an identical skin eruption, pityriasis rosea, rubeola (measles), rubella (German measles), erythema infectiosum (parvo B-19 infection), staphylococcal scalded skin syndrome (SSSS), erythema toxicum neonatorum, infectious mononucleosis (Epstein-Barr virus infection), Kawasaki disease, toxic shock syndrome (TSS), perianal streptococcal dermatitis, other viral exanthems, and drug eruptions.
Laboratory Data
Throat culture or rapid streptococcal antigen testing to identify organism and direct treatment.
Management
Prognosis
Generally excellent if identified and treated promptly. Treatment is indicated to prevent both the nonsuppurative (eg, acute rheumatic fever [ARF], poststreptococcal glomerulonephritis) and suppurative (eg, peritonsillar abscess, mastoiditis, and adenitis) complications of streptococcal infection, and to reduce the symptoms from strep pharyngitis.
PEARL/WHAT PARENTS ASK
Skin
|
Associated Findings
Erythema Marginatum (Rheumatic Fever)
Synonym
Erythema marginatum rheumatica and erythema annulare.
Inheritance
n/a
Prenatal Diagnosis
n/a
Incidence/Prevalence
6% to 10% of patients with ARF; incidence of ARF following streptococcal pharyngitis is ~0.5% to 3% of infected patients (0.23-1.88 patients per 100,000 population).
Age at Presentation
ARF occurs most often in patients aged 6 to 20 years and rarely occurs after the age of 30.
Pathogenesis
Complication of GABHS pharyngitis (not cellulitis), exact pathophysiologic pathway is not known; erythema marginatum is not a diagnosis but a sign underlying ARF.
Key Features
Differential Diagnosis
Drug reactions, urticaria, hereditary angioedema, streptococcal infections without rheumatic fever, erythema multiforme, urticaria multiforme and other viral exanthems, Kawasaki syndrome, and juvenile idiopathic arthritis.
Laboratory Data
High index of suspicion, throat culture is gold standard in diagnosis acute streptococcal pharyngitis; rapid streptococcal antigen test (RST) very high sensitivity, negative RST cannot exclude GABHS so culture should be obtained to confirm the negative RST; clinical diagnosis of streptococcal pharyngitis without a positive culture has a very low sensitivity.
Management
Prognosis
Prognosis is related to underlying ARF complications. Erythema marginatum (as a sign of ARF) will resolve with time though it can recur or remain present for months to years.
PEARL/WHAT PARENTS ASK
Skin
|
Associated Findings
Staphylococcal Scalded Skin Syndrome (SSSS)
Synonym
Ritter von Ritterschein disease, Ritter disease, and staphylococcal epidermal necrolysis.
Inheritance
n/a
Prenatal Diagnosis
n/a
Incidence
~8 cases per million children, 45 cases per million in children <2 years.
Age at Presentation
Generally appears before 6 years of age.
Pathogenesis
Bacterial toxin-mediated from strains of S. aureus (SA) phage group 2 strains 55 and 71; less commonly types 3A, 3B, 3C, and ST121; toxins cleave desmoglein 1 (keratinocyte-to-keratinocyte adhesion molecule in upper epidermis of nonmucosal skin); predisposing infection or bacterial colonization; renal immaturity and lack of antibodies prevents excretion of toxins leading to clinical findings; site of entry/source of infection is often not identified; may be from mild bacterial infections as impetigo, conjunctivitis, and minor wounds; rarely from more severe illnesses as pneumonia, sepsis, and endocarditis.
Key Features
Differential Diagnosis
Bullous impetigo, cellulitis, irritant/allergic contact dermatitis, burns, Stevens-Johnson syndrome, toxic epidermal necrolysis, child abuse/neglect, scarlet fever, TSS, and pemphigus foliaceus.
Laboratory Data
Bacterial culture of any suspected sites of cutaneous infection or (if none are found) other common sites of colonization (eg, nares, conjunctivae, and nasopharynx) to determine susceptibilities; is helpful to confirm diagnosis though are not always positive; almost all are MSSA, rarely MRSA; clindamycin resistance is rising (~30%-40% in recent studies); ESR often elevated; biopsy not generally necessary though will see subcorneal blister formation with possible acantholysis (loss of intercellular attachments), and inflammation not a typical feature.
Management
![]()
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
Get Clinical Tree app for offline access